News

Picture of healthy food

How lifestyle changes can support women with breast cancer

A study published in the British Journal of Cancer, and funded by Anticancer Fund, shows how lifestyle changes can support women during advanced breast cancer treatment. Read the full insights on how diet and exercise may become a vital part of breast cancer care.

Pano documentary picture

Cancer patients misled by costly and unproven treatments abroad

Doctors abroad are offering cancer patients unproven treatments without hesitation, often charging thousands of euros. That is revealed in the TV-documentary Pano, aired by the Belgian public broadcaster VRT, and to which Anticancer Fund contributed.

First patient in EViDENCE BM trial to test personalised treatment for brain metastases

Brain metastases are difficult to treat, often leaving patients with cancer with limited options and less favourable outcomes. The EViDENCE BM trial, just lauched, is designed to validate a cutting-edge personalised approach that could change the future of care for patients with brain metastases.

Foto mensen met logo De Warmste Week

De Warmste Week: lighting a flame for people living with invisible illness

We've been selected as one of the charities for De Warmste Week, and this year we’re joining the flame for people who suffer out of sight. With the funds raised, we’ll set up workshops to help people cope with the often hidden consequences of cancer.

2 different pills

Pancreatic cancer: early results of PROSPER-trial with repurposed medication show potential to improve outcomes

Researchers have completed the PROSPER trial, a clinical study examining whether two commonly available medications—propranolol and etodolac—could improve outcomes when administered around the time of pancreatic cancer surgery.

Drugs spilled on a blue background

Breaking new ground in bringing repurposed drugs to patients

The European Medicines Agency (EMA) has released findings from its Pilot Program on drug repurposing, marking a significant step toward establishing new regulatory pathways that could transform how existing medicines are developed for new therapeutic uses across Europe.